Cogent Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Cash & Equivalents	53.23	141.14	220.94	243.45	38.68	56.93	29.6	42.58
Short-Term Investments	212.48	119.39	0	0	0	22.92	12.69	27.19
Cash & Cash Equivalents	265.71	260.53	220.94	243.45	38.68	79.85	42.29	69.76
Cash Growth	1.99%	17.92%	-9.24%	529.40%	-51.56%	88.81%	-39.38%	-
Receivables	0	0	0	0	2	1.67	0.83	0.93
Other Current Assets	5.06	4.44	1.69	1.47	-0.09	-0.52	-0.74	-0.96
Total Current Assets	270.77	264.97	222.63	244.91	40.59	81	42.38	69.73
Property, Plant & Equipment	30.34	31.1	4.48	4.75	7.15	3.25	4.11	4.56
Long-Term Investments	7.46	0	0	0	0	0	0	0
Other Long-Term Assets	4.86	4.75	4.98	1.26	1.68	1.67	2.63	1.26
Total Long-Term Assets	42.67	35.84	9.46	6	8.83	4.93	6.74	5.82
Total Assets	313.44	300.81	232.09	250.92	49.42	85.93	49.12	75.55
Accounts Payable	10.66	5.84	3.48	0.73	3.18	1.52	1.35	1.45
Deferred Revenue	0	0	0	0	1.32	17.95	15.61	19.48
Current Debt	1.39	1.42	2.32	2.05	1.62	0	0	0
Other Current Liabilities	26.13	19.58	11.27	10.31	7.13	5.48	-5.76	-12.2
Total Current Liabilities	38.17	26.85	17.08	13.09	13.25	24.95	11.19	8.74
Long-Term Debt	17.47	18.23	0.83	3.16	4.41	0	0	0
Other Long-Term Liabilities	0	0	0	0	0	0.75	9.62	14.43
Total Long-Term Liabilities	17.47	18.23	0.83	3.16	4.41	0.75	9.62	14.43
Total Liabilities	55.64	45.08	17.91	16.25	17.66	25.69	20.81	23.16
Total Debt	18.85	19.65	3.16	5.21	6.03	0	0	0
Debt Growth	-4.05%	522.79%	-39.41%	-13.68%	-	-	-	-
Retained Earnings	-603.62	-411.21	-270.97	-198.7	-123.89	-92.06	-51.34	-25.85
Comprehensive Income	0.25	-0.1	0	0	0	-0.01	-0.02	-0.02
Shareholders' Equity	257.8	255.74	214.18	234.67	31.76	60.23	-48.85	-24.7
Net Cash / Debt	246.86	240.88	217.78	238.24	32.65	79.85	42.29	69.76
Net Cash / Debt Growth	2.48%	10.61%	-8.59%	629.74%	-59.11%	88.81%	-39.38%	-
Net Cash Per Share	3.10	4.10	5.62	21.50	4.28	12.83	16.60	27.38
Working Capital	232.6	238.12	205.56	231.82	27.34	56.06	31.19	61
Book Value Per Share	3.24	4.35	5.53	21.18	4.17	9.68	-19.17	-9.70

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).